Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

PHASE4CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

September 30, 2005

Conditions

Breast Cancer With Metastatic Bone Disease

Interventions

DRUG

Zoledronic acid

Trial Locations (7)

Novartis Investigative Site, Ankara

Novartis Investigative Site, Antalya

Novartis Investigative Site, Bursa

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Izmir

Novartis Investigative Site, Kayseri

Novartis Investigative Site, Trabzon